This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simpson, J. Search for Related Content PubMed PubMed Citation Articles by Simpson, J. Related Collections Pediatric Endocrinology Thyroid

Serum Thyroid Hormones in Preterm Infants and Relationships to Indices of Severity of Intercurrent Illness

Maternal and Child Health Sciences (J.S., C.D., R.H.) and Community Health Sciences (F.L.R.W., S.A.O.), University of Dundee, Dundee DD1 9SY, Scotland, United Kingdom; Department of Internal Medicine (H.v.T., T.J.V.), Erasmus University Medical School, 3000 DR Rotterdam, The Netherlands; and Nuclear Medicine Service (S.-Y.W.), VA Medical Center, University of California–Irvine Medical Center, Long Beach, California 90822-5201

Address all correspondence and requests for reprints to: Professor Robert Hume, Maternal and Child Health Sciences, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, United Kingdom. E-mail: r.hume{at}dundee.ac.uk.

The purpose of this study was to relate severity of illness at 1, 7, 14, and 28 postnatal days in preterm infants groups, 23–27 (n = 73), 28–30 (n = 160), and 31–34 (n = 208) wk gestation, to the corresponding sera levels of T₄, free T₄, T₄-binding globulin, TSH, T₃, rT₃, and T₄ sulfate. The British Association of Perinatal Medicine and Neonatal Nurses Association 1992 scoring categories (published elsewhere) were used as an index of illness severity: level 1 (maximal intensive care) was compared with level 2 (high-dependency intensive care) combined with level 3 (special care); infants were scored on 1, 7, 14, and 28 postnatal days. In level 1 infants, there were significant reductions in T₃ at 7 d (28–30 wk), 14, and 28 d (23–27 and 28–30 wk); T₄ at 7, 14, and 28 d (23–27 wk); at 14 and 28 d (28–30 wk); and at 7 d (31–34 wk); and free T₄ at 14 d (23–27 wk). TSH was unchanged in all groups at all ages and with reductions in T₄ and T₃ being the key features of severe illness in extreme preterm infants.

This article has been cited by other articles:

				E. F. La Gamma, A. G. van Wassenaer, S. Ares, S. G. Golombek, J. H. Kok, J. Quero, T. Hong, M. H. Rahbar, G. M. de Escobar, D. A. Fisher, et al. Phase 1 Trial of 4 Thyroid Hormone Regimens for Transient Hypothyroxinemia in Neonates of <28 Weeks' Gestation Pediatrics, August 1, 2009; 124(2): e258 - e268. [Abstract] [Full Text] [PDF]

				A. J. Forhead, J. K. Jellyman, D. S. Gardner, D. A. Giussani, E. Kaptein, T. J. Visser, and A. L. Fowden Differential Effects of Maternal Dexamethasone Treatment on Circulating Thyroid Hormone Concentrations and Tissue Deiodinase Activity in the Pregnant Ewe and Fetus Endocrinology, February 1, 2007; 148(2): 800 - 805. [Abstract] [Full Text] [PDF]

				F. L. R. Williams, S. A. Ogston, H. van Toor, T. J. Visser, R. Hume, and with collaboration from the Scottish Preterm Thyro Serum Thyroid Hormones in Preterm Infants: Associations with Postnatal Illnesses and Drug Usage J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5954 - 5963. [Abstract] [Full Text] [PDF]

				F. L. R. Williams, G. J. Mires, C. Barnett, S. A. Ogston, H. van Toor, T. J. Visser, R. Hume, and with collaboration from the Scottish Preterm Thyro Transient Hypothyroxinemia in Preterm Infants: The Role of Cord Sera Thyroid Hormone Levels Adjusted for Prenatal and Intrapartum Factors J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4599 - 4606. [Abstract] [Full Text] [PDF]